Intimation regarding receipt of approval from the Competition Commission of India ("CCI") to the Scheme of Amalgamation of Indovida India Private Limited with EPL Limited and their respective ....
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 27 May 2026, 05:25 PM IST · BSE ID: 5c136afa-4d32-4d19-89d3-89422c8c204b
View Original BSE Filing (PDF)
💡
In Simple Terms
The government's competition watchdog has approved EPL Ltd's plan to merge with Indovida India Private Limited.
🤖 AI Summary
- EPL Ltd received Competition Commission of India (CCI) approval for amalgamation with Indovida India Private Limited.
- CCI conveyed approval via letter dated May 26, 2026, under Section 31(1) of the Competition Act, 2002.
- This approval follows EPL's Board of Directors' resolution on March 29, 2026, for the merger scheme.
- Previous filings indicated the combined entity would have an INR 8,377 Crore turnover.
- The detailed order from the Competition Commission of India is currently awaited.
🏢 How This Affects the Company
This approval removes a significant regulatory hurdle for the amalgamation of Indovida India Private Limited with EPL Ltd, facilitating the creation of the combined entity.
The merger, previously indicated to form a combined entity with an INR 8,377 Crore turnover, progresses towards completion, which may integrate Indovida India's financials into EPL's going forward.
The regulatory clearance allows for the integration of Indovida India's operations, potentially leading to revised operational structures and capacities for the combined entity.
The receipt of CCI approval reduces the regulatory risk associated with the merger, moving the company closer to completing the amalgamation as planned.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this regulatory approval.
👤
Who Is Affected
Shareholders of EPL Ltd are affected as the company progresses towards integrating Indovida India, potentially altering the future structure and financial performance of their holdings. Previous filings projected a combined entity with INR 8,377 Crore turnover.
🔍
Management Signal
Management is progressing with its strategic objective of amalgamating Indovida India Private Limited to enhance the company's scale and market position.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Receipt of detailed CCI order — verify specific conditions of approval.
SEBI and NCLT approvals — monitor further regulatory clearances.
Completion of amalgamation — track the effective date of the merger.
LOW RISK
The filing reports a positive regulatory approval, reducing a key risk for the planned amalgamation.
💡 Investor Takeaway
EPL Ltd obtained Competition Commission of India (CCI) approval on May 26, 2026, for the amalgamation with Indovida India Private Limited, a critical step towards completing the merger that earlier projected an INR 8,377 Crore combined turnover.
⚖️ Strengths & Concerns
✅ Positives
- Receipt of CCI approval reduces regulatory uncertainty for the merger scheme, advancing the amalgamation process.
- Previous filings indicated a combined entity turnover of INR 8,377 Crore, suggesting a larger scale post-merger.
📅 Company Track Record
EPL Ltd's Board of Directors approved the Indovida India merger on March 29, 2026. This scheme was projected to create a combined entity with an INR 8,377 Crore turnover, with the completion contingent on various regulatory clearances including from SEBI, NCLT, and CCI.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What regulatory approval did EPL Ltd receive on May 27, 2026?
EPL Ltd received approval from the Competition Commission of India (CCI) for its Scheme of Amalgamation with Indovida India Private Limited.
When did the CCI convey its approval to EPL Ltd for the Indovida India merger?
The CCI conveyed its approval to EPL Ltd via its letter dated May 26, 2026, under Section 31(1) of the Competition Act, 2002.
What was the previously indicated combined turnover for the entity formed by the EPL and Indovida merger?
Previous intimations from March 29, 2026, indicated the combined entity would have an INR 8,377 Crore turnover.
What other regulatory approvals are still required for the EPL Ltd and Indovida India merger?
The merger scheme is subject to other necessary statutory and regulatory approvals under applicable laws, including from SEBI and NCLT, as stated in earlier filings.
Questions based on this BSE filing only. For information purposes.